SCHEMBL20149107

SCHEMBL20149107

O=C(Cc1ccncc1)N1C[C@@H](Cc2ccccc2)[C@H](c2ccc(-c3c(F)cccc3F)cc2)C1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
RORC P51449 15/20 1.00
CCR5 P51681 1/20 0.46
PAX8 Q06710 1/20 0.41
TACR3 P29371 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23713119 0.87 RORC (1.00) RORCCCR5PAX8
SCHEMBL23713020 0.86 RORC (1.00) RORCCCR5PAX8
SCHEMBL23713011 0.81 RORC (1.00) RORCCCR5
SCHEMBL20149105 0.78 RORC (1.00) RORC
SCHEMBL23713149 0.76 RORC (1.00) RORCCCR5TACR3
SCHEMBL20139698 0.74 RORC (0.65) RORCCCR5PAX8
SCHEMBL20139701 0.74 RORC (0.65) RORCCCR5PAX8
SCHEMBL20149049 0.73 RORC (0.56) RORCCCR5
SCHEMBL23683586 0.73 RORC (0.56) RORCCCR5
Hydrochloric Acid SCHEMBL23683618 0.72 RORC (0.55) RORCCCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11078186-B2 ROR γ modulators BRISTOL-MYERS SQUIBB COMPANY (US) 2021-08-03 US disclosed
WO-2018089406-A1 ROR GAMMA MODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11078186-B2 ROR γ modulators RORB, RORC, RORA RORC 2/4885CCR5 742/4885PAX8 618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.